Fundraising FoxGreen Park & Golf Ventures
Venture capitalDallas · Pre-Seed–Growth · 10 people tracked
Also known as GPG Ventures
Find your way into Green Park & Golf Ventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask David Norris to introduce you to Claire England
You →David · together at Affineon →Claire
Ask Jamie Chen to introduce you to JR Garcia
You →Jamie · together at FedEx Services →JR
Ask Sam Okafor to introduce you to Carl Soderstrom
You →Sam · together at Illinois State University →Carl
- Drew Soderstrom132 people can intro you
- Lauren Tyra90 people can intro you
Sign up to find every way you can get introduced to Green Park & Golf Ventures
- Your email: who you already know at Green Park & Golf Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Green Park & Golf Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Green Park & Golf Ventures pursues investment opportunities in medical-related startups that can deliver above-market returns. Building on the founders' operational track record from MedicalEdge and PhyServe, the firm seeks disruptive, fresh ideas addressing large markets with high barriers to entry, backed by passionate, seasoned management teams of two or more people. It values companies that treat others with compassion and dignity and that align incentives across owners, management and employees. Typical investments range from $500,000 to $2,000,000, deployed as either start-up or growth capital, with the firm's level of involvement varying based on the entrepreneur's needs and the company's stage.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website
What they invest in
from 53 of 66 portfolio companiesHealthtech ×34Medical Devices ×20Biotech ×19Digital Health ×13AI & Machine Learning ×12SaaS ×11Enterprise Software ×8Deep Tech ×7
HQs:United States×42Sweden×1
Who they back
founder profiles across 27 portfolio companiesFounding team size:solo founder×172 founders×83 founders×14+ founders×1
Where their founders studiedfrom 25 founders with education data
The University of Texas at Austin ×3Northwestern University ×2Stanford University ×2Texas A&M University ×2The Wharton School ×2
What their founders studiedfrom 27 founders with field-of-study data
Engineering ×7Business & Management ×4Finance & Accounting ×4Medicine ×4Humanities ×3Life Sciences ×3Physics ×3Computer Science ×2
Where their founders worked beforefrom 25 founders with career history
Flexera ×2
5 founders hold a PhD · 5 hold an MBA (of 30 with degree data)
Investments · 66 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 42022 · 12021 · 22019 · 32018 · 42017 · 22016 · 12014 · 119 dated
Lantern Pharma is a pharmaceutical biotechnology company that applies machine learning and AI to oncology drug development, using data-driven hypothesis testing with in vitro and in vivo models.
AI & Machine LearningBiotechHealthtechDallas, US
Arunkumar Asaithambi(Director)David R. Margrave(Chief Financial Officer, Secretary)inPanna Sharma(Chief Executive Officer, President)inKishor G. Bhatia(Chief Scientific Officer)inDavid Keyser(Director)John Fucci(Director)
Co-investorsHealth Wildcatters
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved treatment for stroke survivors with moderate to severe upper extremity impairment.
Digital HealthHealthtechMedical DevicesAustin, US
Richard John Foust(Executive Officer, Director)Frank McEachern(Executive Officer, Director)in
BoardNelson Bunker Curnes(Executive Officer, Director)Thomas Jordan Curnes II(Executive Officer, Director)Casey Tansey(Director)Dana Mead(Director)
Co-investorsLongitude CapitalUT Horizon FundUS Venture Partners
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.
BiotechHealthtechMedical DevicesAustin, US
Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)inMike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)inSantosh J. Vetticaden(Executive Officer)Gregory D. Gorgas(Executive Officer)Patrick Keran(Executive Officer)
Co-investorsBain Capital Life SciencesCentral Texas Angel NetworkKeiretsu ForumMoore Venture PartnersNew Enterprise Associates (NEA)
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications.
BiotechHealthtechMedical DevicesNew MaterialsBedford, US
James Biggins(Chief Executive Officer, President and Founder)inDennis Byrne(Chief Commercial Officer)inScott Blood(VP of Regulatory and Quality)inKatie Motherway(VP of Human Resources)inPaul Sabin(Director)Joseph Pellegrino(Director)
Co-investorsTVM Capital Life ScienceTVM Capital
Austin, US
Mark S. Wochner(Executive Officer, Director)in
BoardJR Garcia(Director)inRina Hartline(Director)John Paulos(Director)Laurence Walker(Director)
Co-investorsCentral Texas Angel Network
Affineon Health builds automation tools for healthcare providers and care teams, reducing administrative and tedious tasks so clinicians can focus on patient care.
AI & Machine LearningDigital HealthHealthtech
Ryan Van Wert(Physician Executive / Co-founder)inEvan(Executive (former COO Zus Health, CPO Codametrix, CPO Innovaccer))Tony(CTO)Dan(CFO & COO)Abid Siddiqui(Chief Operating Officer)in
Co-investorsAI FundBenhamou Global VenturesCity LightHeadwater VenturesLoup VenturesSignal Peak Ventures
Avanta Risk Management provides PACE (Property Assessed Clean Energy) identification and risk management services to the mortgage and real estate industries.
Data & InfrastructureEnterprise SoftwareFintechInsurTechLegalTechPropTech
Co-investorsNaples Technology Ventures
Barricade Therapeutics is a biotech company focused on oncology drug development, working to advance cancer treatments through evidence-based clinical pharmacology.
BiotechHealthtechFort Worth, US
Neil C. Thapar(Co-Founder, Board Chairman, CEO & Chief Scientific Officer)inJohn Walling(Co-Founder, SVP, CMC)inMariam E. Morris(Chief Operating Officer)Scott Jordan(Chief Financial Officer)
Betaliq is a clinical-stage pharmaceutical company developing topical eye-drop therapies for glaucoma using a licensed water-free drug delivery platform (EyeSol).
BiotechHealthtechMedical DevicesTarpon Springs, US
Oliver Schlueter(Executive Officer, Director)Barry Butler(Founder & Chief Executive Officer)Oliver Schlüter(Chief Financial Officer)Ronil Patel(Chief Operating Officer)Haley Lemon(Executive Officer)
BoardChristian Roesky(Director)
Co-investorsEvolution VC Partners
HealthtechBothell, US
Stephen Morse(Executive Officer, Director)inCaitlin Morse(Executive Officer, Director, Promoter)
BoardAndrew Chomer(Director)
Co-investorsIn-Q-TelProta Ventures
Cariloop provides digital and human-centered support services to relieve stress and anxiety experienced by family caregivers.
Enterprise SoftwareHealthtechHR TechImpact & Social GoodSaaSDallas, US
Michael Walsh(Co-Founder, Chief Executive Officer, and Board Chair)inSteven Theesfeld(Executive Officer, Director)in
BoardMichael Stoltz(Director)
Co-investors1843 CapitalABS Capital PartnersHealth WildcattersKCRise FundNoro-Moseley PartnersRevolution+1 more
Carpe is a dermatologist-recommended skincare brand that produces antiperspirant and sweat-control products with active ingredients designed to block sweat at the source while managing moisture and odor.
ConsumerDirect to ConsumerHealthtechWellness & FitnessUnited States, US
Co-investors7BC Venture CapitalDuke Capital PartnersIrishAngelsOval Park Capital
HealthtechEmeryville, US
Bill Malecki(Executive Officer)Daniel Burnett(Director)Ulric Cote(Executive Officer, Director)
BoardDr. Jason Hong(Director)Anthony Natale(Director)inCarter Mayer(Director)
Co-investorsAPERTURE Venture PartnersScientific Health DevelopmentThird Point VenturesLongwood FundVHM
CounterFind provides AI-enhanced brand protection software and services that detect and remove counterfeit listings, fraudulent websites, and infringing content across marketplaces, social media, and the web.
AI & Machine LearningCybersecurityLegalTechSaaSFrisco, US
Darren Woodson(Co-founder & Chairman)inJamie Gerson(Co-founder / Head of Strategic Partnerships & Infringement Recovery)inRachel Aronson(Co-founder / Head of Business Development & Marketing)inDon Adam(CEO)inMichael DeCoursey(Executive Officer, Director)Robert Wechsler(Director)
Co-investorsCapital Factory
BiotechDraper, US
Martin Wensley(Executive Officer)Jeffrey Williams(Executive Officer, Director)Michael Hufford(Executive Officer, Director)
BoardFraser Bullock(Director)Christopher B Munday(Director)Richard Brenner(Director)
EarthView develops BluBird, a continuous emissions monitoring system that detects, locates, and quantifies gas leaks in real time.
CleantechClimate TechDeep TechEnergyHardwareDallas, US
Bear Givhan(Co-founder & CEO)inJim Maslanik(Co-founder & Chief Scientist)inJohn Reed(Executive Officer, Director)inFrederick Bear Givhan(Executive Officer, Director)Kevin Yoon(VP of Product)in
BiotechOmaha, US
Danial Burnett(Director)Carter Meyer(Director)Evan Luxon(Director)Deepak Gangahar(Director)Alan Chesler(Director)
Genomenon uses AI to read biomedical literature and expert scientists to curate variant- and patient-level genomic evidence, delivering regulatory-grade real-world evidence.
AI & Machine LearningBiotechDigital HealthAnn Arbor, US
Mark Kiel(Chief Scientific Officer & Co-Founder)inEli Salembier(Executive Officer, Director)inSam Globus(Executive Officer)inMike Klein(Chief Executive Officer)inDavid Gregorka(Director)inBrian Groark(Executive Officer)in
Co-investorsBeringeaID VenturesInvest MichiganIrishAngelsMarram VenturesMichigan Rise+1 more
GlycosBio conducts research and development using engineered lipid technologies to improve the bioavailability and therapeutic performance of natural bioactive molecules, including approaches targeting the intestinal, pulmonary, and skin microbiota.
BiotechDeep TechHealthtechHouston, US
Richard C. Jr. Cilento(Executive Officer, Director)
BoardDan Watkins(Director)Frank Foster(Director)inJoseph Walowski(Director)Victoria Niklas(Director)
Co-investorsGideon Hixon FundTexas HALO FundFuture VenturesMercury Fund
Hypergiant develops AI-enabled software platforms that process data and deliver actionable intelligence for rapid decision-making, serving Fortune 500 companies and government agencies.
AI & Machine LearningData & InfrastructureDefense TechEnterprise SoftwareAustin, US
Co-investorsPerot Jain
Hyperseed provides a no-code billing automation platform that uses spreadsheet formulas to let companies manage custom billing workflows, eliminating manual processes and reducing the need for custom engineering solutions.
Enterprise SoftwareFintechSaaSSan Francisco, US
Hootan Mahallati(Founder)inGeorg Untersalmberger(Founder)in
Co-investorsY CombinatorK5 GlobalPareto Holdings
Iterion Therapeutics is a clinical-stage biopharmaceutical company developing cancer therapies targeting the Wnt/β-catenin pathway.
BiotechHealthtech
Rahul Aras(Chief Executive Officer)inOvid Trifan(Chief Medical Officer)inSteve Horrigan(Chief Scientific Officer)in
Co-investorsLumira VenturesPortal Innovations
Empirical Spine develops the LimiFlex Dynamic Sagittal Tether, a spinal stabilization implant intended to treat patients with degenerative lumbar spinal disorders while preserving spinal function as an alternative to spinal fusion.
HardwareHealthtechMedical DevicesSan Carlos, US
Louie Fielding(Co-founder)inTodd F. Alamin(Co-Founder and Medical Director)Marcia Wachna(Vice President of Clinical Affairs)in
Co-investorsScientific Health Development
MAUI develops ultrasound imaging technology that can penetrate through bone, metal, and other barriers to provide clinical visualization otherwise requiring CT or MRI scans.
AI & Machine LearningDeep TechHardwareHealthtechMedical DevicesTucson, US
Don Specht(Founder)inDave Specht(CEO)
BoardLevi Moore(Director)John Miller(Director)Alexandra M. Lopez(Director)Said Bolorforosh(Director)
MetaSaaS, now part of Flexera, provides a SaaS management platform that discovers, analyzes, and optimizes SaaS and AI applications across an organization, including shadow IT.
Cloud ComputingEnterprise SoftwareFintechSaaSAustin, US
Arlo Gilbert(Executive Officer, Director)inScott Hertel(Director)in
Co-investorsChicago Ventures
Mission Bio develops single-cell biology tools and platforms for researchers and clinicians to enable precision medicine discovery and cancer treatment.
BiotechDeep TechDigital HealthMedical DevicesSouth San Francisco, US
Adam Sciambi(Founder)inAdam Abate, Ph.D.(Director)Charles Silver(Chief Executive Officer, Treasurer, Secretary and Director)Maneesh Jain, Ph.D.(Director)
BoardPaul Billings, M.D., Ph.D.(Director)Urshit Parikh(Director)
Co-investorsAlumni VenturesCota CapitalFusionKeiretsu ForumMighty CapitalSand Hill Angels+1 more
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment.
HealthtechMedical Devices
Jordan Curnes(Co-Founder)in
Co-investorsLongitude CapitalOUP (Osage University Partners)US Venture Partners
Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time.
Digital HealthHardwareHealthtechMedical DevicesGalveston, US
Donald Prough(Clinical Vice President)inGraham L. Randall(Executive Officer, Director)David J. Giarracco(Chief Executive Officer)inThomas Luby(Director)Michael Lowe(Director)
Co-investorsHealth WildcattersRockies Venture ClubTexas VenturesTMC Venture FundPhilips Ventures
NovaScan develops a platform technology combining AI and spectral bioimpedance for oncology applications, with multiple diagnostic and intraoperative products built on a shared hardware and software foundation currently in clinical trials.
AI & Machine LearningHealthtechMedical Devices
Co-investorsDipalo VenturesHarvard Business Angels of ChicagoPortal Innovations
OncoNano Medicine develops a proprietary nanotechnology platform for cancer therapeutics that targets the acidic tumor microenvironment to improve drug delivery to tumors.
BiotechDeep TechHealthtechMedical DevicesDallas, US
Melissa Paoloni(Executive Officer)inMatthew Head(Executive Officer)inKartik Krishnan(Executive Officer, Director)inGina Guillem Jones(MMS, PhD)Benjamin Qui(CFA, CMA)Joydeep Goswami(Director)
OneDay creates interactive video pages and automated video campaigns powered by AI.
Marketing TechSaaS
Co-investorsSilverton PartnersVolition Capital
VistaApex Solutions is a dental healthcare company formed by uniting the VistaApex, PerioProtect, and PerioSciences brands, offering products such as antioxidant-based oral care, FDA-cleared non-invasive tray therapy for gum disease, and clinical endodontic and operatory materials.
ConsumerDirect to ConsumerHealthtechMedical DevicesWellness & Fitness
Russell Moon(Founder)in
Co-investorsCowtown Angels
symplr Directory centralizes and governs provider data across healthcare organizations, helping health plans and health systems maintain accurate, compliant provider information for credentialing, claims, and member-facing systems.
Digital HealthEnterprise SoftwareHealthtechSaaS
Co-investorsFirst Trust Capital PartnersInvest NebraskaRex Health VenturesBessemer Venture PartnersWellington Management
Prolocor is developing diagnostic tests related to atherosclerotic cardiovascular disease and thrombotic risk, including platelet FcγRIIa-based assessment of risk in cancer patients.
BiotechDigital HealthHealthtechMedical DevicesPhiladelphia, US
Peter M. DiBattiste(Co-founder & CEO)inDavid J. Schneider(Co-founder & CSO)in
Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams.
AI & Machine LearningBiotechHealthtechMedical DevicesPhiladelphia, US
David West, Jr.(Executive Officer, Director)David West(Executive Officer, Director)inDavid West, Sr.(Executive Officer, Director)
BoardAlex Niehenke(Director)inTom Loftus(Director)Robert Epstein(Director)
Co-investorsAlpha Intelligence CapitalEmerald Development ManagersFlybridge Capital PartnersFusionHitachi VenturesInterwoven Ventures+9 more
Radformation develops automation software for radiation oncology, including tools for deep-learning contouring, treatment planning, plan evaluation, independent calculations, treatment monitoring, billing QA, and machine QA.
AI & Machine LearningHealthtechMedical DevicesSaaSNew York, US
Kurt Sysock(Executive Officer, Director, Promoter)inKurt S(Co-Founder & CEO)Alan N(CTO, Co-founder)Liz V(Co-founder & CXO)Karl O(CSO)
Co-investorsBessemer Venture PartnersTexas VenturesThe Fund
Recuro is a virtual-first digital health platform that provides primary care, behavioral health, urgent care, and supplemental benefits (pharmacy, care management, advocacy) to patients, employers, health plans, and providers.
Digital HealthHealthtechSaaSRichardson, US
Michael Brombach(Chief Executive Officer and Co-Founder)inMichael Gorton(Chief Executive Officer)inDr. Kate Sowerwine(Chief Medical Officer)John Halsey(Director)Kris Engskov(Director)inWilliam Paiva(Director)
Co-investors1843 Capital4D CapitalARCH Venture PartnersCortado VenturesCure VenturesGlobal Insurance Accelerator+4 more
Alto operates a vertically integrated electric rideshare fleet in the US, running vehicles and W-2 drivers on the Uber platform (Uber Black, Uber XL, UberTeen) while building depot, charging, maintenance, and fleet management infrastructure to support autonomous vehicle operations.
CleantechLogistics & Supply ChainMobility & Transportation
Will Coleman(Founder)in
Co-investorsEscalate Capital PartnersRoad VenturesTuesday Capital
Semler Scientific develops FDA-cleared medical devices for early detection of vascular diseases, particularly peripheral arterial disease, serving healthcare providers and patients.
Digital HealthHealthtechMedical DevicesBoston, US
Dr. Herbert J. Semler(Founder)
Stingray is an oncology-focused biotech company developing drugs from discovery through clinical development to commercialization, led by scientists and physicians with experience in building oncology companies.
AI & Machine LearningBiotechHealthtechHouston, US
Jonathan Northrup(Chief Executive Officer, Co-Founder)inSunil Sharma(Chief Medical Officer, Co-Founder)inScott Andrew Jordan(Executive Officer, Director, Promoter)
Co-investorsCatalytic Impact Foundation
Supergoop! is a suncare brand that develops SPF sunscreen products, including formulas for the whole family across different skin tones and activities.
ConsumerDirect to ConsumerWellness & Fitness
Holly Thaggard(Founder)in
Co-investorsElizabeth Street VenturesGrace Beauty CapitalSWAT Equity PartnersTq Ventures Llc
Take Command Health provides platforms that enable small employers and larger organizations to offer employee health insurance reimbursement through QSEHRA and ICHRA programs, bringing transparency and affordability to health insurance shopping.
HealthtechHR TechInsurTechSaaSPhiladelphia, US
Jack Hooper(Founder)in
Co-investorsSJF VenturesEdison PartnersLiveOak Ventures
Telperian is a clinical innovation company that provides biostatistical analytics and technology solutions to optimize drug development and reduce the cost and complexity of clinical trials.
AI & Machine LearningBiotechData & InfrastructureDigital Health
Dr. Brian Hobbs(Scientific Advisor and Founder)
TheraNova is a venture studio and incubator that develops medical devices from concept through clinical trials, regulation, and commercialization using a shared R&D model.
BiotechHealthtechMedical DevicesSan Francisco, US
Developer of next-generation insulin solutions
BiotechWaban, US
Richard Berenson(Executive Officer, Director, Promoter)David C. Sweeney(Director)
BoardTim Xiao(Director)inJohn Brooks(Mr. Brooks is the Chairman of the Board of Directors.)
Co-investorsDelos CapitalRobin Hood VenturesJumpstart VenturesSanofi Ventures
Validic operates a health IoT platform that connects over 700 medical devices and health apps to health systems, health plans, and life sciences organizations for clinical use.
Data & InfrastructureDigital HealthHealthtechIoT
Drew Schiller(Founder)in
Co-investorsKaiser Permanente VenturesNTT DOCOMO VenturesSJF VenturesTech WildcattersBIP Capital
WorkShield provides workplace investigation services and misconduct management solutions to help employers conduct consistent, documented, and defensible investigations into employee complaints and policy violations.
Enterprise SoftwareFuture of WorkHR TechLegalTechSaaSDallas, US
Jared Pope(Founder)Jennifer Pope(Co-founder)Travis Foster(Co-founder)
Worlds develops AI technology for processing and analyzing visual data in spatial and temporal context to enable enterprise applications in the physical world.
Advanced ManufacturingAI & Machine LearningDeep TechEnterprise Software
Dave Copps(CEO)inChris Rhode(President)
Co-investorsMoneta VenturesPiva CapitalPerot JainPETRONAS Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Heartis Brookfield InvestorsHeartis North Shore InvestorsHeartis Suwanee InvestorsArcheioAtaiaAtaiamedicalCageneDiscover EchoGregor DiagnosticsGregordiagnosticsRemindRtrs TechSendinc
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 5
3 IPOs · 2 acquisitionsLantern PharmaNASDAQ: LTRNMicroTransponderNASDAQ: MOBISavaraNASDAQ: SVRAPhyndacq. by symplrValidicacq. by ChartSpan
Portfolio news
latest coverage across their companiesProscia · insightpartners.com · Feb 19, 2026
Maui Imaging · mauiimaging.com · Jul 29, 2025
Frequently asked questions
- How many investments has Green Park & Golf Ventures made?
- Green Park & Golf Ventures has 66 tracked investments, 5 of which have exited, including 5 dated in the last 24 months.
- What stage does Green Park & Golf Ventures invest at?
- Green Park & Golf Ventures invests at the Pre-Seed, Seed, Series A, Series B, Growth stages.
- What is Green Park & Golf Ventures's typical check size?
- Green Park & Golf Ventures typically writes checks of $500K – $2M.
- What sectors does Green Park & Golf Ventures focus on?
- Green Park & Golf Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Green Park & Golf Ventures located?
- Green Park & Golf Ventures is headquartered in Dallas, US.
- Does Green Park & Golf Ventures lead rounds?
- Green Park & Golf Ventures has led 3 of the 6 rounds where its role is on record.
- Who does Green Park & Golf Ventures co-invest with?
- Green Park & Golf Ventures most often shares deals with Health Wildcatters, Fusion, IrishAngels, among 83 tracked co-investors.
Co-investors · 1
What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.
Firms observed investing alongside Green Park & Golf Ventures, from public investor directories. Shared companies are the overlap with Green Park & Golf Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
The Novartis Venture Fund invests in innovative life science companies, primarily in biotechnology and biopharmaceuticals, at various stages of development across North America and Europe.